跳至主要内容
临床试验/CTRI/2013/09/003950
CTRI/2013/09/003950已完成4 期

A PROSPECTIVE RANDOMIZED, OPEN-LABEL, COMPARATIVE TRIAL ON EFFICACY AND SAFETY OF ASENAPINE Vs OLANZAPINE IN MANIC EPISODE OF BIPOLAR-1 DISORDER PATIENTS - RAO

nil0 个研究点目标入组 120 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • OPD patients
  • Patient free of psychotropic drugs for at least 1 month
  • Age > 18 or < 55 yrs
  • Legitimate consent
  • Those who meet DSM-IV-TR criteria for acute mania in Bipolar1 disorder (American Psychiatric Association, 2000).

排除标准

  • Pregnancy, lactation
  • H/o epilepsy
  • Presence of uncontrolled, unstable, clinically significant medical condition
  • Narrow angle glaucoma
  • Primary psychiatric disorder other than bipolar
  • History of substance dependence
  • History of rapid cycling ((American Psychiatric Association, 2000)
  • Judged by the clinical investigator - inability to reduce intake of lorazepam to a maximum of 4 mg per day
  • Intolerant or allergic to the drug

研究者

发起方
nil

相似试验